EP0183136A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
A hemostatic agent composed of collagen/gelatin and protamine
Assignee: Koken Co Ltd
•
Filing: 1985-11-13
•
Granted: —
•
Expires: 2005-11-13
Abstract
Abstract This invention relates to a hemostatic agent used in surgical operations, which can be produced in two ways: one blending collagen/gelatin with protamine, the other blending collagen/gelatin with protamine and a bi-functional cross-linking agent so as to make said collagen/gelatin have a covalent bond with said protamine. The produced hemostatic agent can stop bleeding within far less time than a conventional hemostatic agent made out of pure collagen.
Inventors
- 👤 Teruo Miyata
- 👤 Kazuhiko Kodaira
- 👤 Masayasu Furuse
- 👤 Yasuharu Noishiki
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-23 21:56
CPC Classifications
A; A61; A61L; A61L15/00; A61L15/07; A61L15/12; A61L15/125; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/39; A61L26/00; A61L26/0009; A61L26/0052; A61L2400/00; A61L2400/04; Y; Y10; Y10S; Y10S128/00; Y10S128/08
Claims Analysis
Total Claims: 2
Claim 1
Independent Claim
14 words
(1) A hemostatic agent, which is produced by blending collagen or gelatin with protamine.
Claim 2
Dependent Claim
33 words
(2) A hemostatic agent, which is produced by blending collagen or gelatin with protamine and a bi-functional cross-linking agent so as to make said collagen or gelatin have a covalent bond with protamine.
References Cited (Backward Citations)
FR2410477A1
Cited
FR2425860A1
Cited
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.